Inverse correlation of free triiodothyronine with glycated albumin and the glycated albumin/glycated hemoglobin ratio in hemodialysis patients: a cross-sectional study

Table 2 Univariate analysis of clinical parameters with GA, GA/HbA1c, and HbA1c in HD patients with DM

DM	GA		GA/HbA1c		HbA1c
DM	r	P	r	P	r	P
Av-PG	0.292	0.016	0.014	0.909	0.297	0.014
HbA1c	0.772	< 0.001	− 0.188	0.124
GA/HbA1c	0.468	< 0.001			− 0.188	0.124
FT3	− 0.228	0.062	− 0.477	< 0.001	0.065	0.598
Age	− 0.082	0.505	0.154	0.210	− 0.221	0.071
Men (= 1)/Women (= 0)	− 0.105	0.393	0.177	0.148	− 0.258	0.034
Hb	− 0.033	0.788	− 0.059	0.634	0.010	0.938
Alb	0.237	0.051	− 0.158	0.200	0.342	0.004
BMI	0.034	0.780	− 0.339	0.005	0.277	0.022
GNRI	0.115	0.351	− 0.309	0.010	0.315	0.007
ChE	0.094	0.447	− 0.453	< 0.001	0.404	0.001
Cr	− 0.095	0.441	− 0.250	0.040	0.064	0.607
P	− 0.024	0.849	− 0.170	0.165	0.101	0.413
T.Chol	0.249	0.040	− 0.137	0.266	0.374	0.002
Log CRP	− 0.096	0.434	− 0.093	0.449	− 0.023	0.850
HD duration	0.263	0.030	0.287	0.018	0.068	0.583
ESA dose	− 0.006	0.959	0.200	0.102	− 0.125	0.311

GA, Glycated albumin; HbA1c, glycated hemoglobin; HD, hemodialysis; DM, diabetes mellitus; r, correlation coefficient; Av-PG, average plasma glucose; FT3, free triiodothyronine; Hb, hemoglobin; Alb, albumin; BMI, body mass index; GNRI, Geriatric Nutritional Risk Index; ChE, cholinesterase; Cr, creatinine; P, phosphate; T.Chol, total cholesterol; CRP, C-reactive protein; ESA, erythropoiesis-stimulating agent

ISSN: 2059-1381